Summary Regulation of insulin release and transmembrane Ca2 + fluxes was examined using pieces of 3 benign medullary-type insulinomas removed from the pancreas of female patients at surgery. Immunocytochemical staining confirmed the presence of insulin-containing cells with no demonstrable glucagon, somatostatin or pancreatic polypeptide. After 3 days of culture in RPMI-1640, tumour pieces released 11-158mg insulin kg-' dry wt during acute 60min incubations with the concomitant uptake of 2-47mmol 45Ca kg-1 into the intracellular lanthanum-nondisplaceable pool. At 2.56 mm Ca2 +, glucose alone or in combination with glyceraldehyde, mannoheptulose or diazoxide did not modify insulin release or 45Ca uptake. Theophylline significantly increased insulin release from 2 tumours with a small stimulatory effect on the third. A depolarising concentration of K+ enhanced insulin release from one tumour but thi,s was not associated with an increase of 45Ca uptake. Calcium antagonists, (verapamil, D-600 and trifluoroperazine) and calcium ionophores (A23187 and Br-X537A) failed to modify insulin release or 45Ca uptake by each of the two tumours tested. Evaluation of 45Ca efflux from one tumour confirmed the unresponsiveness to glucose, K+, verapamil and A23187. Prolonged culture of 2 tumours for up to 16 days was associated with the gradual decline of insulin release to a steady output of 2-15ng 24h-1. Addition of verapamil to the cultures inhibited insulin output from one tumour, but mannoheptulose or diazoxide were without effect. The results indicate that inappropriate insulin release from these 3 benign medullary-type insulinomas is associated with disturbances in the regulation of transmembrane Ca2 + fluxes.
During the past decade, considerable evidence has accumulated concerning the role of metabolic and ionic events in the regulation of pancreatic B-cell function and insulin secretion (Hellman et al., 1979; Wollheim & Sharp, 1981; Malaisse, 1983; Henquin & Meissner, 1984) . Numerous studies with rodent islets indicate that nutrient secretogogues such as glucose are metabolised by the pancreatic B-cells leading to an increase in cytoplasmic Ca2 + concentration and the discharge of insulin by exocytosis. Contributions to cytoplasmic Ca2 + under these circumstances may include displacement of Ca2 + from intracellular sites such as mitochondria and endoplasmic reticulum, inhibition of Ca2 + outward transport across the plasma membrane and stimulation of Ca2+ entry into the B-cell. Several studies using human islets support this mechanism (Ashcroft et al., 1971; Henriksson et al., 1978; Andersson & Hellerstrom, 1980; Grant et al., 1980; Jahr et al., 1983; Harrison et al., 1985) , but analogous studies evaluating defective regulation of insulin secretion by human insulinomas have not been performed.
Insulin-secreting tumours (insulinomas) of the pancreas represent the most common type of enteropancreatic endocrine cancer in man which without clinical intervention can result in debilitation and premature death (Frerichs & Creutzfeldt, 1976; Marks & Rose, 1981; Friesen, 1982; Comi et al., 1986) . Thus despite the relatively low incidence of the disease (1-2 recognised cases per million of the population per annum), the diagnosis and treatment of these heterologous tumours have attracted considerable attention from pathologists and clinicians. In the present study, we report the functional and morphological characterisation of three human benign medullary-type insulinomas. In addition, we have used small pieces of each tumour maintained in tissue culture for in vitro studies on the regulation of transmembrane Ca2 + fluxes, and evaluation of both the acute and long term effects of nutrients and drugs on insulin release.
Materials and methods

Clinical histories
Case I The first tumour was obtained from a 60 year old woman who presented with a 3 year history of 'odd turns' associated with a sense of unreality. Fasting for 36h coupled with moderate exercise produced a fall in plasma glucose concentrations to 1.0 mm, associated with pallor and a feeling of tiredness and mild disorientation. Plasma C-peptide concentrations were consistently inappropriately elevated (1.2-2.5 pg 1-l) during hypoglycaemic episodes. Plasma insulin concentrations were 5.0-10.0 mU 1 At operation, a 0.8 cm diameter tumour was removed from the head of the pancreas. The patient has remained well since operation with no further hypoglycaemic episodes.
Case II The second tumour was obtained from a 45 year old woman who presented with a 6 year history of 'fits' for which she had received treatment with anticonvulsant drugs with limited success. Fasting hypoglycaemia (1.4-1.8 mM) with inappropriately high plasma insulin and C-peptide concentrations (9.6-11.3mUl-1 and 2.3-2.8 g 1-1, respectively) were demonstrated on several occasions once the correct diagnosis had been suspected. A 1.3cm diameter tumour was removed from the body of the pancreas at operation. The patient has since remained well with no recurrence of hypoglycaemic symptoms.
Case III The third tumour was obtained from a 15 year old girl who presented with a 12 month history of recurrent episodes of drowsiness associated with hypoglycaemia (plasma glucose 1.0-2.0mM). After an overnight fast on 2 consecutive days in hospital, she became drowsy and plasma glucose concentrations fell to 1.9-2.2mm. Insulin and C-peptide concentrations at this time were 15.3-23.3 mU -and 3.5-4.1 pg I-1, respectively. At operation, a small tumour was removed from the tail of the pancreas. The patient has remained well since operation and there have been no further episodes of hypoglycaemia.
Special investigations
In addition to measurements of plasma glucose, insulin and C-peptide concentrations in the fed and fasted states, various radiographic and electrophysiological tests were performed. None provided any additional clinically useful information. In Cases I and II, glucose tolerance tests were noncontributory. Oral leucine, i.v. tolbutamide and glucagon tests were also uninformative, and in particular failed to reveal hyperinsulinaemic responses observed in some patients with insulinoma. These tests were not performed in Case III. (Hellman, 1978) . Previous studies have shown that the 45Ca taken up by connective tissue surrounding islet cells is removed by La3 '-washing (Flatt & Swanson-Flatt, 1985) . After freeze-drying overnight and weighing, the tumour pieces were dissolved in 100M1 Soluene (Packard Instruments Ltd., Warrenville, USA). After addition of 5ml Instafluor (Packard), tumour radioactivity was analysed by liquid scintillation spectrometry. Samples of the labelled incubation medium (5pl) were used as external standards in the counting procedure. In the tables, the tumour content of 45Ca is expressed in terms of millimoles of calcium with the same specific radioactivity as that of the incubation medium.
Studies of 45Ca efflux In the case of tumour III, there was a sufficient number of tumour pieces to enable evaluation of 45Ca efflux in addition to the other parameters. For this purpose, groups of 2 pieces of tumour (previously cultured for 3 days) were briefly rinsed and then loaded with 4'Ca during incubation for 90 min in 100M p of the modified KrebsRinger bicarbonate buffer supplemented with 20mM glucose and 2.56mM 45Ca (36OCimol-1). After two 5 min washes in nonradioactive medium containing 3mM glucose, groups of 2 tumour pieces were transferred to 10M, chambers and perifused for 90 min at a constant rate of -40Mi1 minm- (Flatt et al., 1980 (pH 7.4 ) in a gas phase consisting of 5% CO2 in humidified air. The media were changed at 2-5 day intervals. In the case of tumour I, the media were removed at 4, 7, 11 and 14 days. For tumour III, the media were removed at 3, 6, 8, 13 and 16 days. Aliquots of culture media removed at these times were stored at -20°C for insulin assay.
Assays
Plasma glucose was measured by an automated glucose oxidase procedure (Stevens, 1971) . Insulin was determined by dextran-charcoal radioimmunoassay (Flatt & Bailey, 1981) using guinea pig anti-porcine insulin antiserum, 1251-bovine insulin tracer (Amersham International, Amersham, UK) and human insulin standard (23.5 IU mg-1; WHO International Laboratory for Biological Standards, London, UK). C-peptide was measured by double antibody radioimmunoassay (Hampton & Marks, 1979) using reagents supplied by Guildhay Antisera (University of Surrey, Guildford, UK). Parallelism was demonstrated between the insulin and C-peptide standard curves and serial dilutions of either plasma or samples arising from the in vitro investigations. All analyses were performed within 2 weeks of sample collection.
Histology and immunocytochemistry
Several small pieces of each tumour were fixed for a minimum of 24 h in neutral buffered formalin, dehydrated through graded ethanols, cleared in toluene and embedded in paraffin wax for histological and immunocytochemical investigation. Rehydrated paraffin sections (5 gm) were stained with haematoxylin and eosin, or immunostained by the indirect immunoperoxidase technique using guinea pig anti-porcine insulin antiserum (GPB3; PRF/SKS-F), guinea pig anti-porcine glucagon antiserum (GPC4; Flatt & Swanston-Flatt, 1981) and affinity purified donkey antiguinea pig immunoglobulin G conjugated to horse radish peroxidase (Guildhay Antisera). Somatostatin and PP were immunostained by the unlabelled peroxidase anti-peroxidase (PAP) technique (Sternberger, 1979) using the following antisera: rabbit anti-cyclic somatostatin (GR21A; Guildhay Antisera), rabbit and anti-bovine pancreatic polypeptide (GR39PD; Guildhay Antisera), donkey and anti-rabbit immunoglobulin G (Guildhay Antisera) and rabbit PAP complex (Dakopatts, Glostrup, Denmark). Peroxidase activity was visualised using 3,3'-diaminobenzidine and sections were lightly counterstained with Harris' haematoxylin. Control sections were treated with normal serum instead of the hormone antisera.
Statistical analysis
Values are presented as mean + s.e.m. Statistical evaluation was performed using Student's paired and unpaired t-test. Differences were considered to be significant for P < 0.05.
Results
Histology and immunocytochemistry At surgery, an adenoma was removed from the pancreas of each of the patients. This was located in the head, body and tail of the pancreas for patients I, II and III respectively. Tumour metastases in the liver or other organs were not detected, and all patients were still free of hypoglycaemic symptoms 3-4 years after operation.
Immunocytochemical staining of the 3 tumours (Figure 1 ) confirmed the presence of abundant insulin-containing B-cells with no demonstrable staining for glucagon, somatostatin or pancreatic polypeptide. The histological arrangement of cells in each tumour was medullary-type (group B according to classification by Berger et al., 1983) with positive insulin immunostaining cells distributed among negative cells with no polarisation. Tumour I was characterised by an abundant mature fibrous matrix; tumour II was highly vascularised with evidence of focal mineralisation, and tumour III was strongly immunostaining and contained moderate amounts of fibrous connective tissue.
In vitro investigations Acute studies of insulin release and 45Ca uptake As shown in Tables I-III, pieces of tumour from the 3 patients released 1 1-158mg insulin kg-1 dry wt during 60 min incubations with the concomitant intracellular uptake of 2-47mmol 45Ca kg-1. Addition of glucose alone or in combination with glyceraldehyde, mannoheptulose or diazoxide did not modify insulin release or 4'Ca uptake by any of the tumours, with the exception of a small increase of 45Ca uptake by pieces of tumour II exposed to 5.6mM glucose. Addition of theophylline, increased insulin release from tumours II and III by 56-77% without affecting 45Ca uptake. A similar tendency was observed with pieces of tumour I (50% increase), although this did not achieve statistical significance because of the scatter of individual values. However, 25 mM K + stimulated insulin release by 57% from tumour I without affecting 4'Ca uptake. As indicated by Tables I  and III , the calcium -antagonists verapamil, D-600 and trifluoroperazine, and the calcium ionophores A23187 and Br-X537A failed to modify insulin release or 45Ca uptake by pieces of tumours I and III. These agents were not evaluated using tumour II due to shortage of tissue.
Studies of 45Ca efflux The effects of glucose, 25mM K, verapamil and A23187 on 4'Ca efflux following tissue preloading with 4'Ca were examined using pieces of tumour III. As shown in Figures 2 and 3 , the 4'Ca efflux rate from tumour pieces was little affected by addition or removal of these agents from the perifusion media. This unresponsiveness is consistent with the results of acute studies of 4'Ca uptake (Table III) .
Long term studies of insulin release Prolongation of culture for an extended period of 14-16 days was associated with a gradual decline of insulin release to steady outputs of -15 ng insulin 24 h-1 from tumour I ( Figure 4 ) and 2 ng insulin 24h-1 from tumour III ( Figure 5 ) by 4-7 days and 8-13 days, respectively. This progressive decline of insulin Groups of 3-day cultured tumour pieces were incubated for 60min in buffer containing 2.56mM 45Ca (7.8 Ci mol 1), 0, 5.6 or 16.7mM glucose, and the nutrients or drugs as indicated. Radioactivity in tumour pieces was measured after subsequent washing for 60 min with 2 mm LaCl3 at 1°C to remove extracellular and superficially bound 45Ca. The amount of intracellular 45Ca is expressed as mmol of calcium, assuming the same specific radioactivity as in the incubation buffer. Values are mean + s.e.m. of 3-4 observations. ap <0.05 compared with 5.6 mm glucose.
output is commonly observed during the long term culture of insulin-secreting cells (Andersson & Hellerstrom, 1980) . Addition of verapamil to the culture medium inhibited insulin output from pieces of tumour III. In contrast, diazoxide and mannoheptulose did not affect insulin output from tumour III, and neither drug affected tumour I. The demonstration of long term effects of verapamil on tumour III contrasts with the inability of the drug to acutely depress insulin release (Table III) . This delayed action is suggestive of a non-specific effect, possibly on cellular insulin stores (Leinweber & Schatz, 1982 (Berger et al., 1983 8 -13 13 16 Henriksson et al., 1978; Grant et al., 1980; Jahr et al., 1983; Harrison et al., 1985 (Cittadini et al., 1981; Durham & Walton, 1982; Ralph, 1983) . Despite the failure of the tumours to respond as normal insulin secreting cells to nutrients, calcium antagonists and calcium ionophores, all three tumours exhibited evidence of stimulated insulin release in the presence of theophylline. This drug is an established inhibitor of cyclic AMP phosphodiesterase and potentiates insulin secretion through elevation of cyclic AMP without affecting intracellular Ca2 + (Roseman & Abrahamsson, 1985) . This suggests that these tumours may be responsive to agents modulating insulin secretion through the adenylate cyclase-cyclic AMP system (see Lins & Effendic, 1979) , but as demonstrated by Veroni and colleagues (1980) this may not correlate with the apparent responsiveness of such tumours in vivo.
In conclusion, the present study has made a detailed investigation of the regulation of transmembrane Ca2 + fluxes and insulin release in three benign functional medullary-type insulinomas obtained at surgery. The results suggest that inappropriate secretion of insulin from these tumours is associated with, and possibly stems from marked abnormalities in the regulation of voltage-gated Ca2 + channels in the B-cell plasma membrane.
